These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9353141

  • 1. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up.
    Christie JM, Healey CJ, Watson J, Wong VS, Duddridge M, Snowden N, Rosenberg WM, Fleming KA, Chapel H, Chapman RW.
    Clin Exp Immunol; 1997 Oct; 110(1):4-8. PubMed ID: 9353141
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.
    Bjøro K, Frøland SS, Yun Z, Samdal HH, Haaland T.
    N Engl J Med; 1994 Dec 15; 331(24):1607-11. PubMed ID: 7526215
    [Abstract] [Full Text] [Related]

  • 3. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
    Healey CJ, Sabharwal NK, Daub J, Davidson F, Yap PL, Fleming KA, Chapman RW, Simmonds P, Chapel H.
    Gastroenterology; 1996 Apr 15; 110(4):1120-6. PubMed ID: 8613001
    [Abstract] [Full Text] [Related]

  • 4. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status.
    Rossi G, Tucci A, Cariani E, Ravaggi A, Rossini A, Radaeli E.
    Blood; 1997 Aug 01; 90(3):1309-14. PubMed ID: 9242566
    [Abstract] [Full Text] [Related]

  • 5. Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C.
    Chapel HM, Christie JM, Peach V, Chapman RW.
    Clin Immunol; 2001 Jun 01; 99(3):320-4. PubMed ID: 11358426
    [Abstract] [Full Text] [Related]

  • 6. [HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].
    Rostaing L, Izopet J, Moussion F, Alric L, Verdier D, That HT, Duffaut M, Durand D, Puel J, Suc JM.
    Nephrologie; 1997 Jun 01; 18(7):281-6. PubMed ID: 9496568
    [Abstract] [Full Text] [Related]

  • 7. Acute unidentified hepatitis in a hypogammaglobulinaemic patient on intravenous gammaglobulin successfully treated with interferon.
    Lockner D, Bratt G, Lindborg A, Törnebohm E.
    Acta Med Scand; 1987 Jun 01; 221(4):413-5. PubMed ID: 3111178
    [Abstract] [Full Text] [Related]

  • 8. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.
    Ohnishi K, Nomura F, Nakano M.
    Am J Gastroenterol; 1991 Aug 01; 86(8):1041-9. PubMed ID: 1650129
    [Abstract] [Full Text] [Related]

  • 9. Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.
    Sharvadze LG, Gogichaishvili ShSh, Sakandelidze TsG, Zhamutashvili MT, Chkhartishvili NI.
    Georgian Med News; 2009 Jan 01; (166):61-4. PubMed ID: 19202222
    [Abstract] [Full Text] [Related]

  • 10. Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patients.
    Mukherjee S, Lyden E, McCashland TM, Schafer DF.
    J Gastroenterol Hepatol; 2005 Feb 01; 20(2):198-203. PubMed ID: 15683421
    [Abstract] [Full Text] [Related]

  • 11. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.
    Serpaggi J, Chaix ML, Batisse D, Dupont C, Vallet-Pichard A, Fontaine H, Viard JP, Piketty C, Rouveix E, Rouzioux C, Weiss L, Pol S.
    AIDS; 2006 Jan 09; 20(2):233-40. PubMed ID: 16511416
    [Abstract] [Full Text] [Related]

  • 12. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
    Berger A, Doerr HW, Scharrer I, Weber B.
    J Med Virol; 1997 Sep 09; 53(1):25-30. PubMed ID: 9298728
    [Abstract] [Full Text] [Related]

  • 13. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
    Razvi S, Schneider L, Jonas MM, Cunningham-Rundles C.
    Clin Immunol; 2001 Dec 09; 101(3):284-8. PubMed ID: 11726220
    [Abstract] [Full Text] [Related]

  • 14. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA.
    Transplant Proc; 2004 Dec 09; 36(6):1831-4. PubMed ID: 15350490
    [Abstract] [Full Text] [Related]

  • 15. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2004 Dec 09; 19(3):1-46. PubMed ID: 14768714
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients.
    Manesis EK, Papaioannou C, Gioustozi A, Kafiri G, Koskinas J, Hadziyannis SJ.
    Hepatology; 1997 Sep 09; 26(3):734-9. PubMed ID: 9303505
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients.
    Pol S, Thiers V, Carnot F, Zins B, Roméo R, Berthelot P, Bréchot C.
    Nephrol Dial Transplant; 1996 Sep 09; 11 Suppl 4():58-61. PubMed ID: 8918758
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.
    Yedibela S, Schuppan D, Müller V, Schellerer V, Tannapfel A, Hohenberger W, Meyer T.
    Liver Int; 2005 Aug 09; 25(4):717-22. PubMed ID: 15998420
    [Abstract] [Full Text] [Related]

  • 19. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.
    Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Reed A, Hemming A, Howard R, Van Der Werf W, Lauwers G, Liu C, Crawford JM, Davis GL, Nelson DR.
    Liver Transpl; 2002 Nov 09; 8(11):1000-6. PubMed ID: 12424712
    [Abstract] [Full Text] [Related]

  • 20. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A, Mondazzi L, Tempini S, Silini E, Idéo G.
    Eur J Gastroenterol Hepatol; 1997 Dec 09; 9(12):1169-77. PubMed ID: 9471022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.